« Back
Home /
dTAG Targeting Ligand 1

dTAG Targeting Ligand 1

Item no.	HY-75578-25mg
Manufacturer	MedChem Express
CASRN	755039-56-6
Amount	25 mg
Quantity options	1 ea 100 mg 10 mg 25 mg 50 mg 5 mg
Category	Reagents & Chemicals Standards, Ladders & Markers
Type	Standard
Specific against	other
Purity	98.0
Citations	[1]J. Bradner, et al. Targeting proteins are degraded to weaken the relevant bad inflammatory reaction of adoptive T cell therapy. CN108350062A.
Smiles	O=C1[C@@H](CC)N(C2CCCC2)C3=NC(NC4=C(OC)C=C(C=C4)C(O)=O)=NC=C3N1C
ECLASS 10.1	42021590
ECLASS 11.0	42021590
UNSPSC	12352202
Shipping condition	Room temperature
Available
Manufacturer - Type	Reference compound
Manufacturer - Applications	Cancer-programmed cell death
Manufacturer - Targets	Ligands for Target Protein for PROTAC; Polo-like Kinase (PLK)
Shipping Temperature	Room Temperature
Storage Conditions	-20°C, 3 years; 4°C, 2 years (Powder)
Molecular Weight	425.48
Product Description	dTAG Targeting Ligand 1 (SUBSTITUTE SHEET 245) is a PROTAC target protein ligand (Ligand for Target Protein for PROTAC). dTAG Targeting Ligand 1 can be used for synthesis PROTACs [1] .
Manufacturer - Research Area	Cancer
Manufacturer - Pathway	Cell Cycle/DNA Damage; PROTAC
Clinical information	No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 25 mg

available

Request delivery time